Search

Your search keyword '"Kleiman, Neal S."' showing total 42 results
Start Over Author "Kleiman, Neal S." Journal american heart journal
42 results on '"Kleiman, Neal S."'

5. Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry

Author

Crespo, Eric M., Oliveira, Gustavo B.F., Honeycutt, Emily F., Becker, Richard C., Berger, Peter B., Moliterno, David J., Anstrom, Kevin J., Abrams, Charles S., Kleiman, Neal S., Moll, Stephan, Rice, Lawrence, Rodgers, Jo E., Steinhubl, Steven R., Tapson, Victor F., Granger, Christopher B., and Ohman, E. Magnus

Published
2009
Full Text
View/download PDF

10. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa inhibitors (SYNERGY) trial

Author

White, Harvey D., Kleiman, Neal S., Mahaffey, Kenneth W., Lokhnygina, Yuliya, Pieper, Karen S., Chiswell, Karen, Cohen, Marc, Harrington, Robert A., Chew, Derek P., Petersen, John L., Berdan, Lisa G., Aylward, Philip E.G., Nessel, Christopher C., Ferguson, James J., III, and Califf, Robert M.

Subjects
Enoxaparin -- Research, Heparin -- Research, Coronary heart disease -- Care and treatment, Coronary heart disease -- Research, Transluminal angioplasty -- Research, Health
Published
2006

11. Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)u2 trial

Author

Exaire, J. Emilio, Butman, Samuel M., Ebrahimi, Ramin, Kleiman, Neal S., Harrington, Robert A., Schweiger, Marc J., Bittl, John A., Wolski, Kathy, Topol, Eric J., and Lincoff, A. Michael

Subjects
Glycoproteins -- Physiological aspects, Glycoproteins -- Research, Heparin -- Physiological aspects, Heparin -- Research, Clinical trials -- Evaluation, Cardiac patients -- Drug therapy, Cardiac patients -- Physiological aspects, Cardiac patients -- Research, Health
Published
2006

12. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial

Author

Rajagopal, Vivek, Lincoff, A. Michael, Cohen, David J., Gurm, Hitinder S., Hu, Tingfei, Desmet, Walter J., Kleiman, Neal S., Bittl, John A., Feit, Frederick, and Topol, Eric J.

Subjects
Cardiac patients -- Care and treatment, Cardiac patients -- Research, Clinical trials -- Evaluation, Heart attack -- Care and treatment, Heart attack -- Research, Heparin -- Physiological aspects, Health
Published
2006

14. Prevalence, predictors, and outcomes of patients with non–ST-segment elevation myocardial infarction and insignificant coronary artery disease: Results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative

Author

Patel, Manesh R., Chen, Anita Y., Peterson, Eric D., Newby, L. Kristin, Pollack, Charles V., Jr., Brindis, Ralph G., Gibson, C. Michael, Kleiman, Neal S., Saucedo, Jorge F., Bhatt, Deepak L., Gibler, W. Brian, Ohman, E. Magnus, Harrington, Robert A., and Roe, Matthew T.

Published
2006
Full Text
View/download PDF

15. Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial

Author

Exaire, J. Emilio, Butman, Samuel M., Ebrahimi, Ramin, Kleiman, Neal S., Harrington, Robert A., Schweiger, Marc J., Bittl, John A., Wolski, Kathy, Topol, Eric J., and Lincoff, A. Michael

Published
2006
Full Text
View/download PDF

17. Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET)

Author

Lincoff, A. Michael, Kleiman, Neal S., Kottke-Marchant, Kandace, Maierson, Elizabeth S., Maresh, Kelly, Wolski, Katherine E., and Topol, Eric J.

Subjects
The Medicines Co. -- Product information, Thrombosis -- Prevention, Abciximab -- Health aspects, Pharmaceutical industry -- Product information, Health, Angiomax (Medication) -- Evaluation
Published
2002

18. Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting trial and implications for ad hoc use of glycoprotein IIb-IIIa antagonists

Author

Mazur, Wojciech, Kaluza, Grzegorz L., Sapp, Shelly, Balog, Craig, Topol, Eric J., Mark, Daniel B., Ellis, Stephen G., Kereiakes, Dean J., Lincoff, A. Michael, and Kleiman, Neal S.

Subjects
Abciximab -- Evaluation, Stent (Surgery) -- Health aspects, Coronary heart disease -- Drug therapy, Health
Published
2002

21. Dalteparin in combination with abciximab during percutaneous coronary intervention

Author

Kereiakes, Dean J., Kleiman, Neal S., Fry, Edward, Mwawasi, Grace, Lengerich, Rose, Maresh, Kelly, Burkert, Mary Lynn, Aquilina, Joseph W., DeLoof, Michael, Broderick, Thomas M., and Shimshak, Thomas M.

Subjects
Anticoagulants (Medicine) -- Evaluation, Heart attack -- Drug therapy, Unstable angina -- Drug therapy, Health
Published
2001

23. Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions

Author

Kleiman, Neal S., Grazeiadei, Nikki, Maresh, Kelly, Taylor, Rebecca J., Frederick, Bart, Lance, Ellen T., Effron, Mark B., Jordan, Robert E., and Mascelli, Mary A.

Subjects
Blood platelets -- Aggregation, Stent (Surgery) -- Physiological aspects, Ticlopidine -- Evaluation, Health, ReoPro (Medication) -- Evaluation
Published
2000

30. Progressive deterioration of coronary flow reserve after heart transplantation

Author

Mazur, Wojciech, Bitar, Jamil N., Young, James B., Khalil, A. Arif, Vardan, Sandeep, Short, Beth Cocanougher, Rivera, Jose M., Raizner, Albert E., Farmer, John A., Zoghbi, William A., and Kleiman, Neal S.

Subjects
Heart -- Transplantation, Transplantation of organs, tissues, etc. -- Health aspects, Blood flow -- Physiological aspects, Health
Published
1998

32. Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial

Author

Tracy, Russell P., Kleiman, Neal S., Thompson, Bruce, Cannon, Christopher P., Bovill, Edwin G., Brown, R. Greg, Collen, Desire, Mahan, Edward, Mann, Kenneth G., Rogers, William J., Sopko, George, Stump, David C., Williams, David O., and Zaret, Barry L.

Subjects
Blood coagulation factors -- Physiological aspects, Thrombolytic therapy -- Usage, Heart attack -- Development and progression, Coronary heart disease -- Longitudinal studies, Health
Published
1998

33. Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: Design and rationale of the SYNERGY Library

Author

Petersen, John L., Mahaffey, Kenneth W., Becker, Richard C., Goodman, Shaun G., Kleiman, Neal S., Marian, A.J., Stone, Gregg W., Lansky, Alexandra J., Lincoff, A.Michael, Hazen, Stanley L., Nessel, Christopher C., Toro-Figueroa, Luis, Tate, Lynn, Reist, Craig J., Cohen, Marc, Califf, Robert M., and Ferguson, James J.

Published
2004
Full Text
View/download PDF

36. Factors influencing the outcome of balloon aortic valvuloplasty in the elderly

Author

Rodriguez, Arsenio R., Kleiman, Neal S., Minor, Steven T., Zoghbi, William A., West, M. Stewart, DeFelice, Clement A., Samuels, David A., Cashion, Richard, Pickett, J. Dwayne, Lewis, John M., and Raizner, Albert E.

Subjects
Aortic valve stenosis, Balloon dilatation -- Evaluation, Balloon dilatation -- Demographic aspects, Health
Abstract

The aortic valve separates the aorta from the heart's major pumping chamber (the left ventricle), and is necessary to prevent leakage during the refilling of the left ventricle that precedes the pumping cycle. The prevalence of stenosis (constriction) of the aorta and valve due to degenerative calcification (calcium deposits) has increased, and the age of patients with this disorder has also increased. Frequently such patients also have coronary artery disease and other problems involving the kidney or lung, all of which increase the risk of surgical valve replacement. Opening the valve and aorta by a balloon catheter (aortic valvuloplasty) has been tried in such patients, but there is a high rate of symptom recurrence and mortality. In order to determine which patients are most likely to benefit from valvuloplasty as an alternative to valve replacement, the outcomes of the procedure for 42 elderly patients (average age 78 years) were evaluated. The initial success rate was 95 percent; one procedure-related death occurred. Three deaths occurred within one month, but these patients had severe heart failure symptoms prior to the procedure. At discharge, 76 percent of patients had improved, but at 15 months, 10 patients had died and 15 had surgical valve replacement. An indicator of left ventricular function, the ejection fraction (the extent of left ventricle emptying during the pump cycle), was the only factor which affected survival, and it tended to predict event-free survival. The study suggests that balloon valvuloplasty should be reserved for patients who, for noncardiac reasons, should not undergo surgical valve replacement. The extent of repair allowed by balloon valvuloplasty does not seem to be sufficient to allow recovery of heart function in patients with greater than mild heart dysfunction. (Consumer Summary produced by Reliance Medical Information, Inc.)

Published
1990

37. Comparison of quantitative coronary angiography to visual estimates of lesion severity pre and post PTCA

Author

Goldberg, Ronald K., Kleiman, Neal S., Minor, Steven T., Abukhalil, John, and Raizner, Albert E.

Subjects
Angiography -- Evaluation, Transluminal angioplasty -- Evaluation, Coronary arteries -- Abnormalities, Health
Abstract

The coronary arteries are the major blood vessels supplying the heart. Under abnormal conditions, the coronary arteries may become stenosed, or narrowed. Coronary artery stenosis may cause myocardial ischemia, the insufficient supply of blood to the heart, and possibly lead to infarction, the deterioration of tissue due to cessation of blood supply. Coronary artery stenosis can be treated by percutaneous transluminal coronary angioplasty (PTCA), a method in which a balloon attached to a catheter, a tube-like structure, is inserted into the coronary artery, and inflation of the balloon causes dilation or widening of the narrowed vessel. However, coronary artery stenosis may recur after PTCA. The effectiveness of computer-assisted analysis in assessing restenosis lesions was compared with visual estimates in 932 patients. The effect of these assessments on the success of angioplasty and recurrence of stenosis was also examined. There were significant differences between computer-derived measurements and visual estimates of the severity of stenosis before, immediately after and six months after PTCA. Because of these differences in measurements of the severity of stenosis, it was difficult to consistently determine the rate at which stenosis following PTCA would likely occur again and the rate of success with PTCA. The results show that visual estimates rate lesions consistently more severe than computer-derived measurements. (Consumer Summary produced by Reliance Medical Information, Inc.)

Published
1990

Catalog

Books, media, physical & digital resources
See catalog results